심장내 초음파 및 혈관내 초음파 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Intracardiac Echocardiography and Intravascular Ultrasound Market size is expected to reach USD 1.68 Billion in 2034 from USD 1.02 Billion (2025) growing at a CAGR of 5.62% during 2026-2034.

Intracardiac echocardiography and intravascular ultrasound technologies are converging as indispensable imaging modalities for next-generation interventional cardiology. ICE provides real-time, high-resolution intracardiac views that streamline complex structural heart interventions-reducing reliance on fluoroscopy and improving procedural precision. IVUS offers sub-millimeter resolution of vessel wall morphology and plaque composition, enabling accurate stent sizing, optimization, and assessment of lesion morphology during percutaneous coronary and peripheral interventions. Together, these modalities are redefining procedural workflows by enabling physiology-guided, image-driven decision making that improves outcomes and shortens procedure times. As minimally invasive structural therapies proliferate, demand for integrated imaging platforms that combine ICE, IVUS, and adjunctive modalities will intensify.

Technical innovation is driving deeper clinical utility. Advances in high-frequency transducers, catheter miniaturization, and adaptive beamforming are improving spatial resolution while reducing catheter profiles-facilitating access to tortuous anatomy. Software advances such as fusion imaging, automated plaque quantification, and 3D reconstruction are transforming raw data into actionable metrics for interventionalists. Additionally, onboard AI algorithms are beginning to assist in real-time tissue characterization, segmentation, and guidance cues, reducing inter-operator variability and accelerating intra-procedural decisions. Integration with catheter lab information systems and interoperability with robotic navigation platforms will further anchor ICE/IVUS as critical components of the modern hybrid operating environment.

Commercial expansion will be propelled by evidence generation and expanded indications. As registries and randomized studies quantify reductions in radiation exposure, procedural complications, and long-term restenosis when ICE/IVUS is applied judiciously, adoption across tertiary and community centers will broaden. Cost-benefit models that incorporate reduced re-interventions and faster recovery will support payer acceptance, while training curricula evolve to upskill interventional cardiologists and cath lab teams. Opportunities also exist in tele-mentoring and remote interpretation services, where expert review of intravascular imaging can extend advanced care to underserved regions. Overall, ICE and IVUS are positioned to move from niche adjuncts to standard-of-care imaging tools enabling safer, more effective endovascular and structural heart therapies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Electrophysiology Procedures
• Left Atrial Appendage Closure
• Septal Defects
• Others

By End-Use

• Hospitals
• Catheterization Laboratories
• Others

COMPANIES PROFILED

• Abbott Laboratories, Boston Scientific Corporation, Johnson Johnson Services Inc Biosense Webster Inc, Nipro Infraredx Inc, Conavi Medical, Siemens Healthineers AG, Koninklijke Philips NV, GE HealthCare, Medtronic plc, Canon Medical Systems Corp
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Electrophysiology Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Left Atrial Appendage Closure Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Septal Defects Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND MARKET: BY END-USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Application
  • 6.2.2 By End-use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Application
  • 6.3.2 By End-use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Application
  • 6.4.2 By End-use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Application
  • 6.5.2 By End-use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Application
  • 6.6.2 By End-use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott Laboratories
  • 8.2.2 Boston Scientific Corporation
  • 8.2.3 Johnson & Johnson Services Inc. (Biosense Webster Inc.)
  • 8.2.4 Nipro (Infraredx Inc.)
  • 8.2.5 Conavi Medical
  • 8.2.6 Siemens Healthineers AG
  • 8.2.7 Koninklijke Philips N.V
  • 8.2.8 GE HealthCare
  • 8.2.9 Medtronic Plc
  • 8.2.10 Canon Medical Systems Corp